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Abstract: Modular tissue engineering applies biomaterials-
based approaches to create discrete cell-seeded microenviron-
ments, which can be further assembled into larger constructs
for the repair of injured tissues. In the current study, we em-
bedded human bone marrow-derived mesenchymal stem cells
(MSC) and human adipose-derived stem cells (ASC) in colla-
gen/fibrin (COL/FIB) and collagen/fibrin/hydroxyapatite (COL/
FIB/HA) microbeads, and evaluated their suitability for bone
tissue engineering applications. Microbeads were fabricated
using a water-in-oil emulsification process, resulting in an av-
erage microbead diameter of approximately 130 6 25 lm.
Microbeads supported both cell viability and cell spreading of
MSC and ASC over 7 days in culture. The embedded cells also
began to remodel and compact the microbead matrix as dem-
onstrated by confocal reflectance microscopy imaging. After
two weeks of culture in media containing osteogenic supple-
ments, both MSC and ASC deposited calcium mineral in COL/
FIB microbeads, but not in COL/FIB/HA microbeads. There
were no significant differences between MSC and ASC in any
of the assays examined, suggesting that either cell type may
be an appropriate cell source for orthopedic applications. This
study has implications in the creation of defined microenviron-
ments for bone repair, and in developing a modular approach
for delivery of pre-differentiated cells. VC 2013 Wiley Periodicals,
Inc. J Biomed Mater Res Part A: 101A: 1531–1538, 2013.
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INTRODUCTION
Improved therapies for the regeneration of bone are needed
to achieve full repair of recalcitrant and large fractures.
Through the combination of cells, materials, and signaling
molecules, tissue engineering aims to create biomimetic tis-
sue constructs to both regenerate and replace damaged tis-
sue.1 Numerous sources of stem and progenitor cells2 have
been used in bone tissue engineering applications including
embryonic,3 umbilical cord,4 and dental pulp.5 However,
bone marrow-derived mesenchymal stem cells (MSC) and
adipose-derived stem cells (ASC)6 are the most commonly
studied cell types for orthopedic applications and both have
demonstrated the ability to regenerate bone in vivo.7,8 Fur-
ther, both of these cell types has speciﬁc advantages in their
use; MSC have been suggested to have immunomodulatory
properties9 and therefore can be used as an allogeneic
source. ASC have the advantage that they are an easily
obtained autologous cell source.10 A number of recent stud-
ies have directly compared the osteogenic potential of these
two cell types; however the results are context-dependent
and more work is needed to determine the utility of these
cells in speciﬁc applications.11–15
Natural biomaterials such as collagen (COL),16–18 ﬁbrin
(FIB),19,20 and chitosan21,22 have been proposed as osteo-
conductive materials for engineering and regenerating bone.
Ceramics such as b-tricalcium phosphate,18 calcium carbon-
ate,23 bioglass,24 or coatings created by simulated body ﬂuid
(SBF)25 have been combined with these materials to
enhance the mechanical properties and osteoinductivity of
the matrices. In particular, incorporation of hydroxyapatite
(HA), the principal mineral component of native bone, has
proven to be an effective strategy to provide stem cell-
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speciﬁc cues that aid in the formation of biomimetic com-
posite structures for the engineering of bone.15,26,27
Modular tissue engineering has emerged as a scheme
for applying a ‘‘bottom-up’’ approach to fabricate engineered
tissues.28 Cell-seeded, modular hydrogel microenvironments
(‘‘microbeads’’) can be individually cultured, differentiated,
and then later combined to create macroscopic tissue con-
structs with deﬁned architecture. In bone tissue engineer-
ing, recent studies have used gelatin microcarriers to sup-
port osteogenic differentiation of human amniotic ﬂuid MSC
which were then combined to create bone tissue con-
structs.29 Other studies have used alginate microbeads to
differentiate human embryonic stem cells toward the osteo-
blast lineage.30 Previous work in our lab has used various
natural biomaterials including chitosan, FIB, COL, and aga-
rose to create cell-seeded microenvironments through a
water-in-oil emulsion process.31–33 Pure protein microbeads
have been difﬁcult to fabricate using this process because
they are difﬁcult to harvest and are fragile. To circumvent
this issue, the COL matrix can be supplemented with aga-
rose to generate composite microbeads for osteogenic differ-
entiation of encapsulated MSC.34 However, the inclusion of
agarose, a polysaccharide not found in bone, limits the
application of such microbeads in bone repair.
In this study, we generated pure protein microbeads by
combining COL and FIB for bone repair applications. Partic-
ulate HA was also added to the microbeads to increase the
density of microbead preparations, thereby facilitating har-
vesting during the production process. Our primary goal
was to directly compare the osteogenic differentiation of
MSC and ASC in COL/FIB and COL/FIB/HA microbeads.
These modular cell-based hydrogel microenvironments
could provide utility in generating natural biomaterial based
approaches to bone regeneration.
MATERIALS AND METHODS
Collagen/ﬁbrin microbead fabrication
Microbeads composed of 50/50 (mass ratio) COL/FIB were
generated through a water-in-oil emulsion technique as
shown in Figure 1. Bovine type I COL (MP Biomedicals,
Solon, OH) was dissolved in 0.02N acetic acid at a concentra-
tion of 4.0 mg/mL and bovine ﬁbrinogen (Sigma Aldrich, St.
Louis, MO) was dissolved at 4.0 mg/mL clottable protein in
serum-free Dulbecco’s modiﬁed Eagle’s medium (DMEM;
Thermo Scientiﬁc, Logan, UT). COL (1.25 mg/mL) and FIB
(1.25 mg/mL) were then added to a mixture containing 10%
fetal bovine serum (FBS; Life Technologies, Grand Island,
NY), 10% 5-concentrated DMEM (starting concentration),
5% 0.1N NaOH, 2% bovine thrombin (1 UT/mL; Sigma), and
1 mM glyoxal (Sigma) at 4C. The remaining volume for HA-
containing microbeads, 2.5 mg/mL of HA in 1 DMEM, was
sonicated for 1 h prior to incorporation to ensure homoge-
nous distribution throughout the microbeads.35 The HA was
then added directly into the pre-gel mixture.
The pre-gel mixture was then quickly pipetted into a
pre-cooled bath of 100 cSt polydimethylsiloxane (PDMS; Xia-
meter, Dow Corning, Midland, MI) and stirred with a dou-
ble-bladed impeller set at 700 RPM. After 5 min of mixing
at 4C, the temperature was then raised to 37C to initiate
co-polymerization and gelation of the COL and FIB. Microbe-
ads were collected from the oil phase by centrifuging the
mixture at 200g and washing three times for 10 min per
wash with phosphate buffered saline (PBS; Life Technolo-
gies) containing Pluronic L101 (BASF, Florham Park, NJ) in
order to separate the beads from the oil phase and remove
excess oil.
Microbead imaging, size, and size distribution
quantiﬁcation
For light microscopy imaging, microbeads were stained with
EZBlue Coomasie reagent overnight and imaged with an
Olympus IX15 Microscope system (Olympus America, Center
Valley, PA). Confocal reﬂectance microscopy using a laser
scanning microscope (Olympus) was used to acquire images
of the microbead architecture. Microbead diameter was ana-
lyzed using ImageJ software (National Institute of Health,
Bethesda, MD) and size and size distribution of the microbe-
ads were quantiﬁed.
Cell culture
Human marrow-derived MSC (Lonza Inc., Walkersville, MD)
and human ASC (Lonza) were grown in Minimum Essential
Medium Alpha (aMEM) supplemented with 10% MSC-Quali-
ﬁed FBS and 1% penicillin/streptomyocin (Life Technolo-
gies). MSC were used at passage 6 and ASC were used at
passage 5, corresponding to two subculture periods after ar-
rival. Cells were added directly into the pre-gel mix at a
concentration of 1.0  106 cells/mL to promote even cell
distribution throughout the beads. Microbeads were cul-
tured statically in 15-mL centrifuge tubes (Corning Incorpo-
rated, Corning, NY) with 3 mL of media.
Cell viability studies
Cell viability was assessed using a vital stain kit (Live/
DeadV
R
, Life Technologies). At days 1 and 7, cell-seeded
FIGURE 1. Schematic of microbead fabrication process. COL/FIB and
COL/FIB/HA microbeads were formed through a water-in-oil emulsifi-
cation process which resulted in spherical three-dimensional cell-
seeded hydrogel microenvironments. [Color figure can be viewed in
the online issue, which is available at wileyonlinelibrary.com.]
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microbeads were collected and washed three times in ster-
ile PBS for 10 min/wash. Microbeads were then incubated
in a solution containing 4.0 lm calcein-AM and 4.0 lm ethi-
dium homodimer-1 in PBS at 37C for 35 min. Microbeads
were again washed three times in PBS, and then imaged
using a laser scanning confocal microscope (Olympus). Per-
cent viability was calculated by comparing the total green-
stained cells (live) to the total red-stained cells (dead).
Osteogenic differentiation
For osteogenic studies, cell-seeded microbeads were cultured
in either complete medium (growth) or osteogenic medium
FIGURE 2. Morphology and size distribution of acellular microbeads. Coomasie staining allowed for visualization of microbeads under light mi-
croscopy (4, 10). Images of the microarchitecture of microbeads obtained through confocal reflectance (60). The addition of HA did not alter
the size or the size distribution of microbeads. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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composed of complete medium supplemented with 10 mM
b-glycerophosphate (Sigma), 50 lg/mL ascorbic acid 2-phos-
phate (Sigma), and 100 nM dexamethasone (Sigma) for 14
days. Microbead samples were collected at days 1, 3, 7, and 14
and ﬂash-frozen in liquid N2 and stored at 80C. To analyze
cell proliferation and alkaline phosphatase (ALP) activity,
microbeads were dissolved overnight in 10 mM Tris-HCl
(Sigma) containing 0.6 mg/mL COL type I (MP Biomedicals),
0.2% IGEPAL (Sigma), and 2 mM phenylmethanesulfonylﬂuor-
ide (Sigma). DNA content was then assessed using a commer-
cially available DNA assay (PicoGreenV
R
, Life Technologies).
Alkaline phosphatase activity was quantiﬁed by adding 20 lL
of the sample lysate to a 100 lL of 0.5M 2-amino-2-methyl-1-
popanol (Sigma) with 5.0 mM p-nitrophenol phosphate sub-
strate (Sigma) at a pH of 10.3 and read spectrophotometrically
at 405 nm.22 Total calcium secretion was analyzed using the o-
cresolphthalein complexone (OCPC) method as described.35
Brieﬂy, microbead samples were dissolved overnight in 1.0N
acetic acid and 10 lL of the sample was incubated in 0.05 mg/
mL of OCPC solution in ethanolamine, boric acid, and 8-hydrox-
yquinoline buffer (Sigma) for 10 min. Samples were read
against a standard curve with known calcium values at 565 nm.
Statistical analysis
All values are represented as mean 6 standard deviation. N
¼ 4 independent samples were used for the osteogenic
FIGURE 3. Cell viability of MSC or ASC in COL/FIB or COL/FIB/HA microbeads at days 1 and 7. Scale bar ¼ 100 lm. [Color figure can be viewed
in the online issue, which is available at wileyonlinelibrary.com.]
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differentiation studies. DNA content and calcium secretion
data were normalized to day 1 values from within each condi-
tion. A one-way analysis of variance test (ANOVA) and a two-
way ANOVA with a Tukey’s post hoc analysis were used to
determine signiﬁcance between conditions and groups. A value
of p < 0.05 was used to determine statistical signiﬁcance.
RESULTS
Acellular microbead morphology, size, and size
distribution
Figure 2 depicts acellular COL/FIB microbeads directly after
fabrication and shows their regular spheroidal morphology
(panels A–D). Coomasie staining allowed for visualization of
microbeads under light microscopy, and microbeads con-
taining HA were dark due to the attenuation of light passing
through the microbeads. HA remained well-dispersed and
homogeneous throughout the microbeads. Confocal reﬂec-
tance imaging allowed for the visualization of the microbead
architecture (panels E, F). COL/FIB microbeads exhibited a
ﬁbrillar structure whereas the COL/FIB/HA microbeads was
observed to have homogenous distribution of HA through-
out and within its ﬁbrillar structure. The addition of HA did
not signiﬁcantly affect the average size of the microbead
populations, and both had an average diameter of approxi-
mately 130 6 25 lm, with a relatively narrow size distribu-
tion (panels G, H).
FIGURE 4. Confocal reflectance imaging of MSC or ASC in COL/FIB or COL/FIB/HA microbeads at days 1 and 7. Scale bar ¼ 50 lm.
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Cell viability
Cell viability of MSC or ASC in COL/FIB or COL/FIB/HA
beads was assessed at days 1 and 7, and vital staining of
microbeads is shown in Figure 3. Viability remained high
(>90%) at both time points in all conditions as seen by the
abundant green staining and low red staining. By day 7, the
morphology of the embedded cells began to change as they
spread throughout both the matrix and mineral phases of
the microbeads.
Confocal reﬂectance imaging of cell-seeded microbeads
Characterization of matrix architecture was performed using
confocal reﬂectance microscopy, as shown in the representa-
tive image in Figure 4. Changes in matrix architecture in
cell-seeded microbeads were tracked over a 7-day culture
period. At day 1, individual ﬁbers were visible within the
COL/FIB microbeads. However, by day 7, both COL/FIB and
COL/FIB/HA microbeads became denser and the ﬁbrillar
structure of the matrix was less evident. The mineral phase
FIGURE 5. Osteogenic differentiation. (*) denotes statistical significance against growth condition. (@) denotes statistical significance against
MSC COL/FIB. (#) denotes statistical significance against ASC COL/FIB. ($) denotes statistical significance against MSC COL/FIB/HA. (^) denotes
statistical significance against ASC COL/FIB/HA. (&) denotes statistical significance against day 1. (!) denotes statistical significance against
day 7.
1536 RAO, PETERSON, AND STEGEMANN STEM CELLS IN PROTEIN/CERAMIC MICROBEADS
could be discerned in HA-containing microbeads, but did
not change over the 7-day culture period.
Osteogenic differentiation
Figure 5 shows DNA, ALP, and calcium secretion data for
both MSC and ASC in COL/FIB and COL/FIB/HA microbeads
after 14 days in either growth or osteogenic media. In
growth medium, there were no signiﬁcant differences in
DNA content at day 7; however, the MSC COL/FIB/HA group
exhibited signiﬁcantly higher DNA content compared to the
other conditions at day 14. In osteogenic media, the ASC
COL/FIB group showed higher DNA content relative to the
other conditions at day 7; however, there were no signiﬁ-
cant differences at day 14.
ALP activity in microbeads was signiﬁcantly higher at
day 3 in the MSC COL/FIB/HA formulation compared to the
MSC COL/FIB microbeads. The MSC COL/FIB/HA microbe-
ads showed signiﬁcantly higher ALP activity when cultured
in osteogenic media, as compared to growth media. Both
ASC COL/FIB and MSC COL/FIB/HA had statistically greater
ALP activity than the MSC COL/FIB microbeads when cul-
tured in osteogenic media.
Calcium deposition markedly increased at day 14 in
both the MSC COL/FIB and ASC COL/FIB microbeads in
osteogenic media, relative to microbeads cultured in growth
media. However, there were no signiﬁcant differences in cal-
cium deposition between any of the conditions in osteogenic
media at day 14.
A full list of the statistical results generated from two-
way ANOVA analyses is provided in the tables in Figure 6.
DISCUSSION
This study has demonstrated that a simple water-in-oil
emulsion process can be used to create modular microenvir-
onments consisting of native extracellular matrix proteins
supplemented with a ceramic phase. The addition of HA
into the microbeads increased the yield that was harvested,
but did not alter the size or size distribution of the microbe-
ads. COL/FIB and COL/FIB/HA microbeads were spheroidal
and approximately 130 lm 6 25 lm in diameter. In this
range of microbead sizes, a deﬁned number of cells can be
encapsulated within each bead, but cells can also spread
and interact with the microbead matrix. Further, this size
allows sufﬁcient mass transfer through the microbead ma-
trix to the embedded cells, since the maximum diffusion
path for nutrients through tissues has been suggested to be
only 150–200 lm.36 Although not explored in this study, the
microbead size and distribution can be controlled by modu-
lating the impeller speed, oil viscosity, and other fabrication
process parameters.31,32
Analysis of cell viability showed that both MSC and ASC
survived the embedding process and remained viable over at
least a week in culture. Furthermore, after 7 days both MSC
and ASC exhibited a spread morphology indicating that they
associated with the COL and FIB extracellular matrix compo-
nents. Inclusion of HA in the microbeads did not alter either
cell type’s viability or morphology. In addition, confocal reﬂec-
tance microscopy allowed the microarchitecture of microbe-
ads to be visualized. The ﬁbrillar structure of the microbeads
became denser over time, suggesting that the microbeads
were compacted by the embedded cells, a phenomenon that
is commonly observed when cells are seeded within natural
biomaterials.37 Taken together, these ﬁndings suggest that the
microbead environment is conducive to maintenance of living
cells and allows them to retain their active functions.
Comparison of MSC and ASC osteogenic differentiation
in COL/FIB and COL/FIB/HA microbeads suggested that
theses cell types are mostly similar in their responses. Two-
way ANOVA found no signiﬁcant differences between ASC
and MSC in their DNA content, ALP activity, or calcium
secretion over two weeks of culture in either growth or
osteogenic media. Moreover, we did not observe any signiﬁ-
cant differences between the COL/FIB and COL/FIB/HA
matrices in any of the assays, indicating that the addition of
HA did not cause any detrimental effects to stem cell differ-
entiation throughout the culture period. ALP activity, an
early osteogenic marker, was somewhat elevated in the MSC
COL/FIB/HA group, suggesting potential osteoinductive
effects of the COL/FIB microbeads. Calcium secretion, a late
osteogenic marker, increased in both MSC and ASC in COL/
FIB microbeads in osteogenic media compared to growth
media. There were no differences in calcium secretion of ei-
ther MSC or ASC in COL/FIB/HA microbeads in the two
media types, presumably because these matrices already
contained a large amount of exogenous mineral.38
The modular microbead technology we have demon-
strated is aimed at developing new minimally invasive tech-
niques for bone repair. Fabrication of microbeads can be
easily scaled up to create larger populations of microbeads
in a controlled batch process. Cell-seeded microbeads can
be pre-differentiated toward the osteogenic phenotype, col-
lected, concentrated into a paste, and then injected into a
defect site in a minimally invasive manner. The advantages
of such a cell-based therapy are particularly important in
treating recalcitrant bone wounds and non-unions, where
the delivery of appropriately functional cells may be a key
to achieving regeneration.
FIGURE 6. Two-way Analysis of Variance (ANOVA) results.
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CONCLUSIONS
Stem cell-seeded COL/FIB and COL/FIB/HA microbeads are
another tool for modular tissue engineering, and these for-
mulations have particular promise in orthopedic applica-
tions. The embedded MSC and ASC remained viable, exhib-
ited remodeling behavior, and mineralized the matrix in
response to osteogenic cues. This study found only modest
differences in the osteogenic response of MSC and ASC, indi-
cating that either cell type may be a suitable source for
bone tissue engineering.
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